These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20401298)

  • 1. Levofloxacin-induced torsades de pointes.
    Patel PD; Afshar H; Birnbaum Y
    Tex Heart Inst J; 2010; 37(2):216-7. PubMed ID: 20401298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
    Amankwa K; Krishnan SC; Tisdale JE
    Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin.
    Frothingham R
    Pharmacotherapy; 2001 Dec; 21(12):1468-72. PubMed ID: 11765299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvolt T-wave alternans monitoring in a patient with levofloxacin-induced Torsade de Pointes.
    Sahashi Y; Takasugi N; Naruse G; Kubota T; Nishigaki K; Minatoguchi S
    J Electrocardiol; 2018; 51(1):108-110. PubMed ID: 29126547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levofloxacin induced polymorphic ventricular tachycardia with normal QT interval.
    Paltoo B; O'Donoghue S; Mousavi MS
    Pacing Clin Electrophysiol; 2001 May; 24(5):895-7. PubMed ID: 11388112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Torsades de pointes after adenosine administration.
    Teodorovich N; Margolin E; Kogan Y; Paz O; Swissa M
    J Electrocardiol; 2016; 49(2):171-3. PubMed ID: 26850499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant use of levofloxacin and fluconazole leading to possible torsades de pointes.
    Tilton JJ; Sadr R; Groo VL
    J Oncol Pharm Pract; 2019 Dec; 25(8):2004-2006. PubMed ID: 30501378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary adenosine-induced torsades de pointes during fractional flow reserve measurement.
    Degrauwe S; Azzano A; Iglesias JF; Zivelonghi C; Verheye S; Convens C; Vermeersch P; Scott B
    Cardiol J; 2019; 26(5):612-613. PubMed ID: 31701514
    [No Abstract]   [Full Text] [Related]  

  • 11. Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.
    Morganroth J
    Am J Cardiol; 1993 Aug; 72(6):10B-13B. PubMed ID: 8256748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
    Lee DY; Trinh T; Roy SK
    Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moxifloxacin and torsade de pointes.
    Dale KM; Lertsburapa K; Kluger J; White CM
    Ann Pharmacother; 2007 Feb; 41(2):336-40. PubMed ID: 17284508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin induced Torsades de Pointes: case report and review of the literature.
    Rezkalla MA; Pochop C
    S D J Med; 1994 May; 47(5):161-4. PubMed ID: 8047870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable case of torsades de pointes induced by fluconazole.
    Khazan M; Mathis AS
    Pharmacotherapy; 2002 Dec; 22(12):1632-7. PubMed ID: 12495173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Torsades de pointes ventricular tachycardia associated with overdose of astemizole.
    Rao KA; Adlakha A; Verma-Ansil B; Meloy TD; Stanton MS
    Mayo Clin Proc; 1994 Jun; 69(6):589-93. PubMed ID: 8189766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin-induced acquired long QT syndrome with torsades de pointes and myocardial injury in a patient with dilated cardiomyopathy and rectal cancer.
    Chang RY; Lee MY; Kan CB; Hsu WP; Hsiao PC
    J Chin Med Assoc; 2013 Aug; 76(8):466-9. PubMed ID: 23769882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Takotsubo cardiomyopathy associated with torsades de pointes and long QT interval: a case report].
    Okada T; Miyata S; Hashimoto K; Maie K; Mochizuki S
    J Cardiol; 2007 Jul; 50(1):83-8. PubMed ID: 17685032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.